Humira For Ulcerative Colitis Seems Headed Towards Approval, Many Post-market Studies
Executive Summary
Unmet medical need for ulcerative colitis patients who have failed conventional therapy was enough to carry the day for Abbott’s drug at FDA’s Gastrointestinal Drugs Advisory Committee, but the optimal patient population and dose have not been established.